Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilal Bashir

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Diabetes, Obesity & Metabolism|July 24, 2025
Statin therapy and neuropathy in type 1 diabetes: A cross-sectional studyRaabya Pasha, Anoushka Kamath, Zara Linn, et al.
Cureus|February 1, 2023
Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care - Real World Multicentre ExperienceBilal Bashir, Shonagh Haslam, Shaheer Ahmad, et al.
Frontiers in Cardiovascular Medicine|August 22, 2024
Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemiaBilal Bashir, Jonathan Schofield, Paul Downie, et al.
Clinical Therapeutics|May 9, 2021
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral NeuropathyIoannis N Petropoulos, Georgios Ponirakis, Maryam Ferdousi, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 29, 2023
Microvascular complications of obesity and diabetes-Role of bariatric surgeryBilal Bashir, Zohaib Iqbal, Safwaan Adam, et al.
International Journal of Molecular Sciences|December 9, 2023
Impact of Bariatric Surgery on Subtilisin/Kexin Type 9 (PCSK9) Gene Expression and Inflammation in the Adipose Tissue of Obese Diabetic RatsAdrian H Heald, Helene A Fachim, Bilal Bashir, et al.
Atherosclerosis|March 5, 2022
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular riskZohaib Iqbal, Bilal Bashir, Safwaan Adam, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|July 24, 2025
Statin therapy and neuropathy in type 1 diabetes: A cross-sectional studyRaabya Pasha, Anoushka Kamath, Zara Linn, et al.
Cureus|February 1, 2023
Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care - Real World Multicentre ExperienceBilal Bashir, Shonagh Haslam, Shaheer Ahmad, et al.
Frontiers in Cardiovascular Medicine|August 22, 2024
Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemiaBilal Bashir, Jonathan Schofield, Paul Downie, et al.
Clinical Therapeutics|May 9, 2021
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral NeuropathyIoannis N Petropoulos, Georgios Ponirakis, Maryam Ferdousi, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 29, 2023
Microvascular complications of obesity and diabetes-Role of bariatric surgeryBilal Bashir, Zohaib Iqbal, Safwaan Adam, et al.
International Journal of Molecular Sciences|December 9, 2023
Impact of Bariatric Surgery on Subtilisin/Kexin Type 9 (PCSK9) Gene Expression and Inflammation in the Adipose Tissue of Obese Diabetic RatsAdrian H Heald, Helene A Fachim, Bilal Bashir, et al.
Atherosclerosis|March 5, 2022
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular riskZohaib Iqbal, Bilal Bashir, Safwaan Adam, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Pageof 4